Petros Pharmaceuticals, Inc. (PTPI)
OTCMKTS
· Delayed Price · Currency is USD
0.0390
-0.0084 (-17.72%)
At close: May 23, 2025
Petros Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Revenue | 5.11 | 5.11 | 5.82 | 5.99 | 7.81 | 9.56 | Upgrade
|
| Revenue Growth (YoY) | 54.70% | -12.20% | -2.83% | -23.29% | -18.29% | -38.63% | Upgrade
|
| Cost of Revenue | 1.21 | 1.21 | 1.63 | 2.29 | 1.6 | 4.05 | Upgrade
|
| Gross Profit | 3.9 | 3.9 | 4.19 | 3.7 | 6.21 | 5.51 | Upgrade
|
| Selling, General & Admin | 8.7 | 8.75 | 9.26 | 12.21 | 15.59 | 15.67 | Upgrade
|
| Research & Development | 2.62 | 2.62 | 2.41 | 1.74 | 1.79 | 0.46 | Upgrade
|
| Operating Expenses | 14.15 | 14.2 | 14.95 | 19.55 | 24.26 | 22.8 | Upgrade
|
| Operating Income | -10.25 | -10.3 | -10.76 | -15.85 | -18.05 | -17.28 | Upgrade
|
| Interest Expense | -0.56 | -0.56 | -0.54 | -0.6 | -0.37 | -3.05 | Upgrade
|
| Interest & Investment Income | 0.27 | 0.37 | 0.52 | 0.01 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -2.39 | -0.87 | 2.62 | 0.46 | - | -1.68 | Upgrade
|
| EBT Excluding Unusual Items | -12.93 | -11.35 | -8.16 | -15.97 | -18.42 | -22.01 | Upgrade
|
| Asset Writedown | -2.97 | -2.97 | - | -7.46 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | 3.39 | 9.43 | - | Upgrade
|
| Pretax Income | -15.9 | -14.32 | -8.16 | -20.04 | -8.99 | -22.01 | Upgrade
|
| Income Tax Expense | - | - | - | - | - | -1.43 | Upgrade
|
| Net Income | -14.42 | -14.32 | -8.16 | -20.04 | -8.99 | -20.59 | Upgrade
|
| Preferred Dividends & Other Adjustments | 15.25 | 12.48 | 5.65 | - | - | - | Upgrade
|
| Net Income to Common | -29.66 | -26.8 | -13.81 | -20.04 | -8.99 | -20.59 | Upgrade
|
| Shares Outstanding (Basic) | 1 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 395.87% | 268.84% | 5.11% | 90.11% | 103.90% | - | Upgrade
|
| EPS (Basic) | -52.60 | -83.47 | -158.71 | -241.98 | -206.31 | -963.63 | Upgrade
|
| EPS (Diluted) | -52.60 | -83.47 | -158.71 | -241.98 | -206.31 | -963.63 | Upgrade
|
| Free Cash Flow | -3.15 | -2.63 | -7.63 | -12.8 | -11.86 | -15.31 | Upgrade
|
| Free Cash Flow Per Share | -5.59 | -8.19 | -87.62 | -154.54 | -272.32 | -716.66 | Upgrade
|
| Gross Margin | 76.28% | 76.28% | 71.98% | 61.79% | 79.52% | 57.67% | Upgrade
|
| Operating Margin | -200.53% | -201.41% | -184.84% | -264.44% | -231.05% | -180.78% | Upgrade
|
| Profit Margin | -580.22% | -524.20% | -237.26% | -334.40% | -115.05% | -215.35% | Upgrade
|
| Free Cash Flow Margin | -61.68% | -51.40% | -130.99% | -213.57% | -151.86% | -160.16% | Upgrade
|
| EBITDA | -7.43 | -7.46 | -7.48 | -10.25 | -11.17 | -10.62 | Upgrade
|
| EBITDA Margin | -145.35% | -146.02% | -128.46% | -171.01% | -143.00% | -111.11% | Upgrade
|
| D&A For EBITDA | 2.82 | 2.83 | 3.28 | 5.6 | 6.88 | 6.66 | Upgrade
|
| EBIT | -10.25 | -10.3 | -10.76 | -15.85 | -18.05 | -17.28 | Upgrade
|
| EBIT Margin | -200.53% | -201.41% | -184.84% | -264.44% | -231.05% | -180.78% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.